PLCH1 and breast carcinoma: Cells treated with si-PLCH1#1 and si-PLCH1#3 exhibited significantly reduced proliferation compared to the control group on days 3, 4, and 5 (Figure 6D, P < 0.001, P < 0.0001), indicating that PLCH1 is essential for sustaining breast cancer cell growth.